MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer.

As for the initial microarray analysis we observed a highly significant dys-regulation for patients after chemotherapy (adjusted p-value < 0.001, 10-fold increased expression; Fig. 5 ).

also in 132,142 other papers